1. Home
  2. AMWL vs RFL Comparison

AMWL vs RFL Comparison

Compare AMWL & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$10.98

Market Cap

91.2M

Sector

Technology

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.10

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
RFL
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
91.2M
92.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
AMWL
RFL
Price
$10.98
$2.10
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$7.40
N/A
AVG Volume (30 Days)
151.3K
245.4K
Earning Date
05-05-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$3.71
$1.12
52 Week High
$13.45
$3.96

Technical Indicators

Market Signals
Indicator
AMWL
RFL
Relative Strength Index (RSI) 55.90 43.37
Support Level $4.49 $1.21
Resistance Level N/A $3.96
Average True Range (ATR) 0.92 0.26
MACD 0.02 -0.08
Stochastic Oscillator 48.54 16.00

Price Performance

Historical Comparison
AMWL
RFL

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: